Summary.-Mononuclear-cell suspensions of lymph nodes, spleen and blood from 24 patients with active Hodgkin's disease (HD) were studied for possible imbalance of T and B lymphocytes, and T-lymphocyte subsets, using monospecific anti-T antibodies and other reagents. A profile showing T-cell predominance was demonstrated ln lymph nodes and blood, with total T-cells ranging from 50-70% of the cell count. As defined by monoclonal antibodies, 70-85% of the latter comprised the "inducer" subclass, the remainder being "suppressor" cells. There were no essential differences between histologically involved and uninvolved lymph nodes from HD patients, though total T-cell proportions were lower in "normal lymph node" controls. The profiles of spleens electively removed, as part of pre-treatment staging procedures, showed reduced total T-cell numbers, whether these were involved with HD or not. These differences are accounted for principally by fewer T "inducer" cells (24%, in spleen, v. 54% in involved lymph nodes and 47% in "normal" control nodes).
(24%, in spleen, v. 54% in involved lymph nodes and 47% in "normal" control nodes).
Possible explanations for these findings are discussed. Our results demonstrate similar profiles in histologically diseased and normal tissue, rather than any clear imbalance of T-cell proportions which might explain the profound disturbances of T-cell function frequently demonstrated in vivo and in vitro. THE NATURAL HISTORY of Hodgkin's disease (HD) is that of a chronic progressive illness which, untreated, is almost invariably fatal. It is manifested clinically and pathologically by features common to both a true malignancy and a chronic inflammatory process.
The association of HD with often profound disturbances of cell-mediated immunity, in vivo and in vitro, is well recognized (Reed, 1902; Parker et al., 1932; Steiner, 1934; Schier et al., 1956; Aisenberg, 1966; Levy & Kaplan, 1974) and has prompted considerable research to determine whether this is intrinsic to the pathogenesis of HD (Levy & Kaplan, 1974; Eltringham & Kaplan, 1973; Bobrove et al., 1975; Jackson & Parker, 1947; Young et al., 1973) , or a secondary phenomenon related to stage of disease, and reversible after successful therapy (Jackson & Parker, 1947; Sokal & Primikirios, 1961; Sokal, 1973) .
The recognition of 2 functionally distinct major T-cell subclasses, "inducer"/ "helper" and "suppressor"/"cytotoxic" (Rowley et al., 1973; Dutton, 1975; Webb & Jamieson, 1976; Moretta et al., 1977; Evans et al., 1978) has led to the recent development of monoclonal antibodies against T-cell antigens (Kung et al., 1979; Hoffman et al., 1980; Reinherz et al., 1979a Reinherz et al., , b, 1980 which has thus provided a consistently reproducible means of rapidly and accurately quantifying these cells. We report below on our experiments using these reagents, in single-cell suspensions of tissues obtained from HD patients, in order to identify possible T-cell imbalances.
MATERIALS AND METHODS

Patients
Material from 24 patients with active, untreated Hodgkin's disease forms the basis of this report. This comprised lymphocyte suspensions prepared from lymph nodes, spleen and peripheral blood. Histological classification was according to the Rye nomenclature (Lukes & Butler, 1966) . Clinical and pathological staging was according to the Ann Arbor method (Carbone et al., 1971) . Details of the pre-treatment patients are given in Table I . An additional 3 patients were submitted for elective laparotomy and splenectomy. after successful completion of combination chemotherapy, to exclude residual, active intra-abdominal HD, and to act as a guide for future management decisions. For comparison the spleens from these patients were studied using the reagents detailed below.
Controls
A group of 15 normal blood donors (mean age 31 years) provided controls for the patient group. A "normal" lymphoid-tissue control group (mean age 24-5 yr) was provided by 8 tonsils from patients undergoing elective tonsillectomy, and histologically reactive lymph nodes removed to exclude possible relapse, in 2 patients treated several years previously for HD.
In addition, 2 histologically normal spleens obtained at diagnostic laparotomy were studied; one was removed from a patient with Wegener's granuloma and renal failure, the other from a patient with suspected intra-abdominal lymphoma. This diagnosis was unequivocally refuted after histological examination.
Tissue preparation Lymph node.-Surgical biopsy specimens were bisected for histological examination and phenotyping. A single-cell suspension of the latter portion was prepared by teasing out in RPMI 1640. The cells were washed twice in the same medium.
Tonsil.-Single-cell suspensions were prepared as for lymph node.
Peripheral blood.-Lymphocytes were obtained from 50-60 ml of blood separated by centrifugation on a Ficoll-Triosil (LymphoprepR) gradient. The cell layer at the interface was harvested and washed twice in RMPI 1640.
Spleen.-About 8 ml of tissue obtained from spleens removed at staging laparotomy were teased into single-cell suspensions. Mononuclear cells were separated on LymphoprepR and washed twice in PRMI 1640.
Reagents
Monoclonal antibodies reactive with T lymphocytes included the OKT series (Ortho Pharmaceuticals, Raritan, NJ, U.S.A.) and the Leu series (Becton Dickinson Antibody Center, Sunnyvale, CAL, U.S.A.). The Tcell-subset specificity of these reagents has been extensively documented (Kung et al., 1979; Hoffman et al., 1980; Reinherz et al., 1979a , b, 1980 . Becton Dickinson, 1981 (Table II) . Mature, peripheral T cells OKT4/Leu-3A T "inducer"/"helper" subset OKT6
Cortical thymocyto OKT8/Leu2A T "suppressor"/"cytotoxic" subset B lymphocytes were defined as cells bearing surface immunoglobulin, detected by staining with polyvalent rabbit antihuman Ig (G + M + A + D). Cells expressing HLA-DR were also counted, using antibody DA-2 (antimonomorphic-HLA-DR: Ia-like antigen) (Brodsky et al., 1979 
T lymphocytes
The T-cell proportions found in blood and lymph nodes from patients and controls are detailed in Table III and IV. As defined by our results these tissues show a T-cell predominance in which Erosetting (Er+) and OKT/Leu+ cells comprise 50-70% of all the mononuclear cells.
The majority (70-85%) of T lymphocytes, thus defined, are comprised of cells expressing OKT4/Leu-3A (T "inducer") antigens. In the main, the proportions of cells expressing OKTI/Leu-1-reactive antigen are lower than either OKT3+ cells or the sum of (OKT4/ Leu-3A + OKT8/Leu-2A) but the differences are not significant. The percentages of OKT3+ cells do, however, correlate well with the sum (OKT4/Leu-3A + OKT8/ Leu-2A)+ cells, i.e. T ("inducer" + "suppressor"). Differences in the relative proportions of Er+ and pan-T antigenexpressing cells vary but are not significant. OKT6 antibody to thymic cortical cells was negative in all tissues.
The differences between the percentages of Er+ cells in involved lymph nodes and "normal" controls are significant (Table  III) . There is also an apparently significant difference in the mean proportions of OKT3+ cells between "normal" controls and diseased nodes but not in total Tcell proportions, defined by the sums of (OKT4 + 8) + and (Leu-3A + 2A) + cells.
The surface-antigen profiles of mononuclear cells from "disease control" lymph nodes, do not differ significantly from those in involved nodes. However, there is a significant difference between mean OKT8/Leu-2A (T "suppressor") values in the "disease control" and "normal control" groups (18% and 11% respectively;
No significant difference in results from patient and control blood has been demonstrated. The profiles are comparable to those from lymph nodes.
The data from spleen-cell suspensions however showed several differences (Table  V) : the mean totals of mononuclear cells expressing T-reactive antigens in spleens from patients with untreated HD, were lower than in either blood or lymph node (P < 0-001). They are accounted for by smaller relative proportions of OKT4/Leu-3A+ cells.
The proportions of Er+ cells in pretreatment spleens equate with those in lymph node and blood, and it follows that the difference between the Er+ and OKT/Lev+ population, in spleen, is also significant (P<0.01). In addition the (Madalinski et al., 1970; Wagener et al., 1976; Amlot et al., 1978; Brown et al., 1978) predominant (Er+, OKTI +, OKT3+, LEU-I +) cell population in diseased lymph nodes and peripheral blood from the patient population, the results are essentially identical to those obtained with the respective control tissues: uninvolved lymph nodes from the patients and normal donor blood.
Our results would appear to be at variance with an earlier study (Romagnani et al., 1978) which showed an imbalance of subsets of peripheral-blood T-cells subsets in HD patients. Such cells identified as Er+ cells expressing receptors for either IgM(TIi) or IgG (Ty), have been described by others (Moretta et al., 1977) as subserving "helper"/"inducer" and "suppressor"/" cytotoxic" functions respectively. Romagnani was able to demonstrate a decrease in Tu and an increase in Ty subsets though Tp. lymphocytes remained overall predominant. Gupta & Tan (1980) demonstrated a small but nonsignificant increase in Ty lymphocytes in the blood of children with untreated HD. These reports would thus suggest a relative increase in the "suppressor"/ "cytotoxic" T-cell population in the blood of HD patients. However, the methods for assaying these subpopulations involve reactions with quite different antigenic determinants from those recognized by the monoclonal antibodies, and it cannot be assumed that identical subsets are identified by the two methods.
Neither tonsils nor reactive lymph nodes from patients "cured" of HD might be regarded as appropriate control material for normal lymph nodes, and this reflects the difficulty in obtaining non-diseased lymph nodes, particularly from an age-matched group. Nonetheless, our data do show similar phenotype profiles, particularly in respect of the T "helper":"suppressor" ratios, though the overall degree of T-cell predominance is marginally less than that in lymphnode material from the patient population. The findings accord with previous reports of cell suspensions and frozen sections of normal tissues Janossy et atl., 1980; Poppema et al., 1981) .
Because of the limited selection of histological types available for study, no conclusions can be drawn about possible T-cell differences in the 4 major histological types, though there is a suggestion of a higher proportion of T "inducer" lymphocytes in nodes involved with lymphocyte-predominant HlD than in other subclasses. One lymph node from a patient aged 14, with mixed-cellularity HD, showed a T-helper population > 9000 of all cells, a marked predominance of this T subset. Since most of our patients presented with limited disease, it has not been possible to relate our findings to stage, or subsequent clinical progress.
Splenic T-cell populations may differ from those of lymph node or peripheral blood. A substantial proportion of Er+ cells fails to express either pan-T antigens (OKTI, OKT3, Leu-1]) or "helper"/ "inducer" antigens (OKT4, . This would imply the presence of an additional subset of T-cells, being either an immature population at an intermediate stage of differentiation, or a subset evolved in response to, or intrinsic to the disease process. Alternatively, it is conceivable that such a population could be resident in normal adult spleen. Gupta & Tan (1 980) have demonstrated increased proportions of T-cells bearing IgM receptors in the spleens of their patients, who were, however, all children, mainly with advanced disease or splenic involvement.
The theory of 'ecotaxopathy" proposed by De Sousa et al. (1976) implies a failure in HD of normal T-cell migration and recirculation (ecotaxis) with a preferential accumulation of these cells within the spleen. De Sousa's study of peripheral blood and spleen from 5 patients suggests that this abnormality is intrinsic to HD, and independent of stage or splenic involvement. Hunter et aW. (1977) also demonstrated an overall increase of Er+ cells in the spleens of patients, but most had advanced disease and heavy splenic infiltration, the highest Er values being obtained from the involved spleens. In contrast, Payne et al. (1976) found the highest Er levels in uninvolved spleens, those in diseased spleens being within normal limits. Kaur et al. (1974) found normal levels of Er+ cells in the spleens of HD patients, though responsiveness to PHA was increased.
We have not demonstrated an overall increase in Er+ cells in the spleens of our patients although as discussed above these may well be distinct from those in peripheral nodes and blood. Only 1 patient, a 16-year-old female with nodular sclerosing HD, had heavy splenic involvement. Intriguingly, in this case the proportion of Er+ cells was 78%, whilst 37% of the cells reacted with OKT1.
We conclude that our results, obtained from single-cell suspensions of lymph node, tonsil and peripheral blood, show phenotypic similarities in these tissues rather than any clear abnormalities. Compared with involved and uninvolved lymph nodes, there is a slightly lower T-cell proportion in the "normal" lymphoid control group. The proportional distribution of cells expressing "helper" and "suppressor" antigens is, however, very similar. The proportions of B cells defined by our methods do not vary significantly between tissues, and account for 20% of leucocytes. A normal polyclonal profile is observed, findings similar to those of Bobrove et al. (1975) .
The significance of the findings in the spleens of patients must remain speculative until appropriate numbers of normal controls for comparison are available.
Despite in vivo and in vitro demonstration of defective T-cell function in HD, this does not appear to result from deficiencies in the proportions of the T or B cells or T-subset ratios in diseased tissues. This suggests that some intrinsic functional immune deficiency is a significant feature in the pathogenesis of HD. Further work will attempt to clarify the micro-anatomical relationships of T and B subsets within the HD lesion, and to study some of the functional attributes of T cells from diseased tissues, in the hope of elucidating the nature of Hodgkin's disease.
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